If you wish to logout, click here. You may be prompted to
sign in again in order to view our content.

Login or register to view this section.

Login or register to view this section.

Your account gives you full control over what you receive from us. You must have an active account and be logged in to access certain parts of the website.

Within your account, you will also have the option to receive information from us, such as our magazine and our email newsletters. You may opt in or out of any of these options at any time, and may deactivate your account by contacting us.

We also ask a few questions about you and the information in which you are interested - these are optional, but help us ensure we can deliver you a more personalised experience on our site.

Thomson Reuters has introduced Cortellis for Competitive Intelligence, a product that the company says brings the best of the pharmaceutical data sources owned by Thomson Reuters into a single, intuitive solution

The intellectual property and science business of Thomson Reuters, the provider of intelligent information for businesses and professionals, has announced the launch of its EndNote Basic online offering

Pages

Latest issue

In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.

At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.

New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.